Article
Modeling Patient-Derived Glioblastoma with Cerebral Organoids
1 Mar 2019
Abstract excerpt
The prognosis of patients with glioblastoma (GBM) remains dismal, with a median survival of approximately 15 months. Current preclinical GBM models are limited by the lack of a "normal" human microenvironment and the inability of many tumor cell lines to accurately reproduce GBM biology. To address these limitations, we have established a model system whereby we can retro-engineer patient-specific GBMs using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
